biomarker一个国外教授说他是Roche的Translational Medicine Leader ，这是什么职位？

什么是串联质谱筛查？

串联质谱筛查：两个或更多的质谱连接在一起，称为串联质谱（MS-MS）。

最简单的串联质谱由两个质谱串联而成，其中第一个质谱仪（MS1）作为分离器，第二个质谱仪（MS2）作为分析仪来对混合物直接进行分析。

串联质谱技术可以应用于其他领域：疾病生物标记物（Biomarker? of Diseases），临床毒物学（Clinical Toxicology），治疗药物监测（Therapeutic DrugMonitoring）等等，串联质谱技术结合其他技术，如HPLC分析辅助诊断技术将更广泛的应用于人们的生活。

扩展资料： 串联质谱筛查的质谱串联方式： 一、空间串联((tandem in space) 1、同种类型的质量分析器串联：扇形磁场、扇形静电场串联质谱；四极杆串联质谱；飞行时间串联质谱。

2、混合型串联质谱(hybrid mass spectrometry)：扇形磁场、扇形电场和四极杆串联；扇形磁场、扇形电场和飞行时间质谱串联；四极杆和飞行时间质谱串联；离子阱和飞行时间质谱串联。

二、时间串联((tandem in time) ：离子阱质谱仪；离子回旋共振质谱仪。

参考资料来源： 百度百科-串联质谱仪 百度百科-液相色谱串联质谱仪

marker和ladder有什么区别

细胞调亡时，DNA在核小体间断裂形成的一些DNA片断，经提取后在凝胶电泳上产生n条带的核酸片段组成，由于成梯状，故称之为DNA Ladder。

其形成与细胞调亡密不可分，是判断细胞调亡的重要标准。

当然，DNA Ladder也可作为一种即用型的DNA分子量marker。

DNA Marker是几种分子量已知的DNA片段混合物，主要用途就是作为分子量标准，凝胶电泳时用以定性比对目标DNA分子的大小和浓度。

虽电泳图谱也成梯状，但并非和细胞凋亡直接相关。

此外，marker是个很广义的概念，不止是分子量标准（DNA、蛋白质等）的含义。

生物标志物（biomarker）是现在疾病研究领域的热点。

就感觉来说，ladder更倾向于表示电泳显示的梯状图谱，而marker更倾向于表达一种对照标准。

北京百迈客生物科技有限公司怎么样？

简介：北京百迈客生物科技有限公司（BiomarkerTechnologies），成立于2009年5月，位于北京市顺义区。

公司自成立以来，秉承"生物科技创新，服务社会，造福人民"的企业使命，致力于"打造生物科技创新中心，树立生物产业标志企业"的发展愿景，让生物科技更快，更好的提高人类生活质量。

法定代表人：郑洪坤 成立时间：2009-05-05 注册资本：2680.8687万人民币 工商注册号：110113011894637 企业类型：有限责任公司(自然人投资或控股) 公司地址：北京市顺义区南法信镇顺平路南法信段9号院1幢5层508室

一个国外教授说他是Roche的Translational Medicine Leader ，这是什么职位？

搞医药研究的~下面是工作介绍~ Job Description Who we are At Roche, 80,000 people across 150 countries are pushing back the frontiers of healthcare. Working together, we’ve e one of the world’s leading research-focused healthcare groups. Our ess is built on innovation, curiosity and diversity, and on seeing each other’s differences as an advantage. To innovate healthcare, Roche has ambitious plans to keep learning and growing – and is seeking people who have the same goals for themselves. The Position Job Purpose: Definition and ountability for the delivery of translational medicine activities required to drive exploratory and confirmatory development projects in the Virology portfolio. Definition and ountability for the delivery of clinical strategy and activities to drive Proof of Concept (POC). Support bridges between Research and Development to ensure application of clinical and scientific knowledge to drive POC studies. Support preclinical and clinical activities by applying physician scientist expertise to ensure state-of-the-art bench to bedside to bench knowledge application and generation Primary Responsibilities and ountabilities:? Medical lead in the exploratory phase responsible for Virology Discovery and Translational Area (DTA) deliverables at the project level. ? Key medical interface with Business and Research in exploratory phase (TPP) ? Develops and is ountable for the exploratory CDP (e-CDP) including proof of concept (POC), in consultation with the Clinical development leader, and for ensuring a smooth transition into Clinical Development (CD) ? Is ountable for POC-enabling activities, POC protocol synopses, study protocols, clinical study reports (CSRs) and related regulatory documents ? Is ountable for the overall design and the clinical and scientific content of Experimental Medicine, ? Leads exploratory medicine strategy to advance DA knowledge and improvement in development Team membership:? Represents medical science on Discovery Teams to: ? ensure alignment on strategy between Pharma Development and Discovery ? support target and clinical candidate selection (in collaboration with DA CP) ? provide guidance on benefit/risk assessment and risk mitigation activities.(responsibility shared with Clinical Pharmacologist) ? Core member of the discovery team and DTA Project Team ? Member of the Clinical Team Other:? Propose, establish and lead external collaborations to address strategic and tactical needs of agreed translational science and POC strategies ? Work in partnership with the Biomarker scientist to define and develop biomarker strategies ? Collaborate with the clinical pharmacologist during the confirmatory phase and where required define and lead exploratory translational science activities to support life cycle team and/or disease area strategies ? Joint responsibility with the Clinical Development Leader for the clinical evaluation of new licensing opportunities Who you are You’re someone who wants to influence your own development. You’re looking for pany where you have the opportunity to pursue your interests across functions and geographies, and where a job title is not considered the final definition of who you are, but the starting point. Education/Qualifications: ? MD in a relevant field and extensive scientific knowledge in the area of Hepatitis C and B as well as other viral diseases (HPV, Influenza etc.). Proven record of scientific achievement as evidenced by presentations and publications in peer reviewed journals and a minimum of 4 years post doctoral experience. Significant experience in pharmaceutical medicine or drug development strongly desired. Experience, Skills, Knowledge: Essential ? Demonstrated ess in impacting research direction through research and clinical integration ? Demonstrated clinical research expertise ? Demonstrated ability to independently develop the clinical strategy for early development ? Understanding of contemporary translational research tools, including imaging and biomarkers ? Understanding of the current unmet medical needs in the therapeutic area and able to think beyond current paradigms of care ? Excellent leadership skills ? Highly effective team work and interpersonal skills ? Effective verbal and munication skills in English ? High level of business awareness ? Excellent planning anisational skills ? Analytical thinking Desirable ? Experience in a pharmaceutical and/or biotechnology environment ? Demonstrated track record of filing IND and providing clinical leadership to early stage development programs ? the future evolution of the medical need